Evaluation of efficacy of povidone iodine in eradication of cervical HPV infection

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064461

Enrollment

Unknown

Registered

2022-10-09

Start date

2022-10-08

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical HPV infection

Interventions

Intervention group:4% povidone iodine smear on cervix

Conrol group:None

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. Cervical HPV infection; 3. Agree to participate in the clinical study voluntarily and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. History of iodine allergy; 2. Patients with thyroid disease; 3. Combined pregnancy; 4. Patients who dropped out of clinical trials.

Design outcomes

Primary

Measure	Time frame
HPV typing;	—

Countries

China

Contacts

Public ContactLin Tiecheng

The First People's Hospital of Foshan

102118649@qq.com+86 18038860061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026